The DOI matches its Crossref record; 223 of the 223 references it cites were found in a registry or an index.
Cancer and liver cirrhosis: implications on prognosis and management
Open accessAbstract
Liver cirrhosis, the end-stage of every chronic liver disease, is not only the major risk factor for the development of hepatocellular carcinoma but also a limiting factor for anticancer therapy of liver and non-hepatic malignancies. Liver cirrhosis may limit surgical and interventional approaches to cancer treatment, influence pharmacokinetics of anticancer drugs, increase side effects of chemotherapy, render patients susceptible for hepatotoxicity, and ultimately result in a competitive risk for morbidity and mortality. In this review, we provide a concise overview about the impact of liver cirrhosis on the management and prognosis of patients with primary liver cancer or non-hepatic malignancies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Edge, S. B., & Compton, C. C. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-0985-4 · Cited by 9,029
Management of Hepatocellular Carcinoma: An Update Δσ
Bruix, J., & Sherman, M. (2011) · Hepatology · doi:10.1002/hep.24199 · Cited by 8,103
Transection of the oesophagus for bleeding oesophageal varices
Pugh, R. N. H., Murray-Lyon, I. M., Dawson, J. L., Pietroni, M. C., & Williams, R. (1973) · Journal of British Surgery · doi:10.1002/bjs.1800600817 · Cited by 7,941 · cited 1×
“opathy and ascites as well as serum bilirubin, albumin and prothrombin time (table 1).(21) Sometimes prothrombin index or international normalised ratio (INR) are used instead of prothrombin time.”
MethodMazzaferro, V., Regalia, E., Doci, R., Andreola, S., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M., Morabito, A., & Gennari, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341104 · Cited by 7,186
Cheng, A.-L., Kang, Y.-K., Chen, Z., Tsao, C.-J., Qin, S., Kim, J. S., Luo, R., Feng, J., Ye, S., Yang, T.-S., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70285-7 · Cited by 5,832
Sorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
Ferlay, J., Steliarova-Foucher, E., Lortet-Tieulent, J., Rosso, S., Coebergh, J. W. W., Comber, H., Forman, D., & Bray, F. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2012.12.027 · Cited by 5,263
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
A Model to Predict Survival in Patients With End–Stage Liver Disease
Kamath, P. S., Wiesner, R. H., Malinchoc, M., Kremers, W., Therneau, T. M., Kosberg, C. L., D'Amico, G., Dickson, R. E., & Kim, R. W. (2001) · Hepatology · doi:10.1053/jhep.2001.22172 · Cited by 4,975
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
Valle, J., Wasan, H., Palmer, D. H., Cunningham, D., Anthoney, A., Maraveyas, A., Madhusudan, S., Iveson, T., Hughes, S., Pereira, S. P., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908721 · Cited by 4,406
Forner, A., Llovet, J. M., & Bruix, J. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61347-0 · Cited by 4,022
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
Molina, J. R., Yang, P., Cassivi, S. D., Schild, S. E., & Adjei, A. A. (2008) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)60735-0 · Cited by 3,908
Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification
Llovet, J., Brú, C., & Bruix, J. (1999) · Seminars in Liver Disease · doi:10.1055/s-2007-1007122 · Cited by 3,805
Expanding consensus in portal hypertension
de Franchis, R. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.05.022 · Cited by 3,078
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
European Association for the Study of the Liver (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.010 · Cited by 2,925
Malinchoc, M., Kamath, P. S., Gordon, F. D., Peine, C. J., Rank, J., & ter Borg, P. C. J. (2000) · Hepatology · doi:10.1053/he.2000.5852 · Cited by 2,893 · cited 1×
“jugular portosystemic intrahepatic shunt implantation in patients with liver cirrhosis.(22) A slightly modified version was proposed shortly thereafter aiming to assess the”
BackgroundEASL Recommendations on Treatment of Hepatitis C 2018
Pawlotsky, J.-M., Negro, F., Aghemo, A., Berenguer, M., Dalgard, O., Dusheiko, G., Marra, F., Puoti, M., & Wedemeyer, H. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.026 · Cited by 2,827
Johnson, P. J., Berhane, S., Kagebayashi, C., Satomura, S., Teng, M., Reeves, H. L., O'Beirne, J., Fox, R., Skowronska, A., Palmer, D., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.9151 · Cited by 2,783
D'Amico, G., Garcia-Tsao, G., & Pagliaro, L. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.10.013 · Cited by 2,687
Model for end-stage liver disease (MELD) and allocation of donor livers
Wiesner, R., Edwards, E., Freeman, R., Harper, A., Kim, R., Kamath, P., Kremers, W., Lake, J., Howard, T., Merion, R. M., et al. (2003) · Gastroenterology · doi:10.1053/gast.2003.50016 · Cited by 2,528
de Franchis, R. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.06.004 · Cited by 2,281
Surgery and portal hypertension.
Child, C. G., & Turcotte, J. (1964) · PubMed · Cited by 1,933
Okuda, K., Ohtsuki, T., Obata, H., Tomimatsu, M., Okazaki, N., Hasegawa, H., Nakajima, Y., & Ohnishi, K. (1985) · Cancer · doi:10.1002/1097-0142(19850815)56:4<918::aid-cncr2820560437>3.0.co;2-e · Cited by 1,931
Llovet, J. M., Fuster, J., & Bruix, J. (1999) · Hepatology · doi:10.1002/hep.510300629 · Cited by 1,708
Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
Llovet, J. M., Di Bisceglie, A. M., Bruix, J., Kramer, B. S., Lencioni, R., Zhu, A. X., Sherman, M., Schwartz, M., Lotze, M., Talwalkar, J., et al. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn134 · Cited by 1,653
Lammer, J., Malagari, K., Vogl, T., Pilleul, F., Denys, A., Watkinson, A., Pitton, M., Sergent, G., Pfammatter, T., Terraz, S., et al. (2010) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-009-9711-7 · Cited by 1,557
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
Bridgewater, J., Galle, P. R., Khan, S. A., Llovet, J. M., Park, J.-W., Patel, T., Pawlik, T. M., & Gores, G. J. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.01.021 · Cited by 1,511
Schmoll, H. J., Van Cutsem, E., Stein, A., Valentini, V., Glimelius, B., Haustermans, K., Nordlinger, B., van de Velde, C. J., Balmana, J., Regula, J., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds236 · Cited by 1,510
Llovet, J. M., Ducreux, M. P., Lencioni, R. A., Bisceglie, A. M. D., Dufour, J., Greten, T. F., Raymond, É., Roskams, T., Mazzaferro, V., Bruix, J., et al. (2012) · Cited by 1,488
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
Kim, W. R., Biggins, S. W., Kremers, W. K., Wiesner, R. H., Kamath, P. S., Benson, J. T., Edwards, E., & Therneau, T. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801209 · Cited by 1,486
American Joint Committee On Cancer (2010) · Springer eBooks · doi:10.1007/978-0-387-88443-1 · Cited by 1,386
The burden of liver disease in Europe: A review of available epidemiological data
Blachier, M., Leleu, H., Peck-Radosavljevic, M., Valla, D.-C., & Roudot-Thoraval, F. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.12.005 · Cited by 1,341
Self-citationA new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients
(1998) · Hepatology · doi:10.1002/hep.510280322 · Cited by 1,238
EASL Recommendations on Treatment of Hepatitis C 2015
(2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.03.025 · Cited by 1,156
Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects
Forner, A., Reig, M. E., Rodriguez de Lope, C., & Bruix, J. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1247133 · Cited by 1,110
Compensated cirrhosis: Natural history and prognostic factors
Ginés, P., Quintero, E., Arroyo, V., Terés, J., Bruguera, M., Rimola, A., Caballería, J., Rodés, J., & Rozman, C. (1987) · Hepatology · doi:10.1002/hep.1840070124 · Cited by 1,106
EASL Clinical Practice Guidelines: Liver transplantation
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.10.006 · Cited by 1,082
Peck, M., Craxì, A., Fried, M., & Zeuzem, S. (2013) · Cited by 1,079
Khan, S. A., Thomas, H. C., Davidson, B. R., & Taylor-Robinson, S. D. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67530-7 · Cited by 1,042
The Liver and Portal Hypertension.
(1964) · Annals of Internal Medicine · doi:10.7326/0003-4819-61-6-1206_2 · Cited by 1,033
Mechanisms of adverse effects of anti-VEGF therapy for cancer
Kamba, T., & McDonald, D. M. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603813 · Cited by 990
Risk factors for cholangiocarcinoma
Tyson, G. L., & El-Serag, H. B. (2011) · Hepatology · doi:10.1002/hep.24351 · Cited by 956
Bruix, J., Castells, A., Bosch, J., Feu, F., Fuster, J., Garcia-Pagan, J., Visa, J., Bru, C., & Rodes, J. (1996) · Gastroenterology · doi:10.1016/s0016-5085(96)70070-7 · Cited by 895
Resection and Liver Transplantation for Hepatocellular Carcinoma
Llovet, J. M., Schwartz, M., & Mazzaferro, V. (2005) · Seminars in Liver Disease · doi:10.1055/s-2005-871198 · Cited by 879
The Survival Benefit of Liver Transplantation
Merion, R. M., Schaubel, D. E., Dykstra, D. M., Freeman, R. B., Port, F. K., & Wolfe, R. A. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00703.x · Cited by 872
Reddy, K. R., Beavers, K. L., Hammond, S. P., Lim, J. K., & Falck-Ytter, Y. T. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.10.039 · Cited by 861
Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy
Lok, A. S. F., Liang, R. H. S., Chiu, E. K. W., Wong, K.-L., Chan, T.-K., & Todd, D. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90599-g · Cited by 827
Novel advancements in the management of hepatocellular carcinoma in 2008
Llovet, J. M., & Bruix, J. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.022 · Cited by 815
Two-Stage Hepatectomy: A Planned Strategy to Treat Irresectable Liver Tumors
Adam, R., Laurent, A., Azoulay, D., Castaing, D., & Bismuth, H. (2000) · Annals of Surgery · doi:10.1097/00000658-200012000-00006 · Cited by 801
Evidence-Based Incorporation of Serum Sodium Concentration Into MELD
Biggins, S. W., Kim, W. R., Terrault, N. A., Saab, S., Balan, V., Schiano, T., Benson, J., Therneau, T., Kremers, W., Wiesner, R., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.010 · Cited by 790
Ishizawa, T., Hasegawa, K., Aoki, T., Takahashi, M., Inoue, Y., Sano, K., Imamura, H., Sugawara, Y., Kokudo, N., & Makuuchi, M. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.091 · Cited by 754
Okusaka, T., Nakachi, K., Fukutomi, A., Mizuno, N., Ohkawa, S., Funakoshi, A., Nagino, M., Kondo, S., Nagaoka, S., Funai, J., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605779 · Cited by 744
The new liver allocation system: Moving toward evidence-based transplantation policy
Freeman, R. B., Wiesner, R. H., Harper, A., McDiarmid, S. V., Lake, J., Edwards, E., Merion, R., Wolfe, R., Turcotte, J., & Teperman, L. (2002) · Liver Transplantation · doi:10.1053/jlts.2002.35927 · Cited by 724
Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?
Shaib, Y. H., Davila, J. A., McGlynn, K., & El-Serag, H. B. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2003.11.030 · Cited by 683
Burroughs, A., Dufour, J.-F., Galle, P., Mazzaferro, V., Piscaglia, F., Raoul, J., Sangro, B., & Bolondi, L. (2013) · Seminars in Liver Disease · doi:10.1055/s-0032-1329906 · Cited by 641
Adam, R., de Gramont, A., Figueras, J., Kokudo, N., Kunstlinger, F., Loyer, E., Poston, G., Rougier, P., Rubbia-Brandt, L., Sobrero, A., et al. (2015) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2015.06.006 · Cited by 607
Mazzaferro, V., Bhoori, S., Sposito, C., Bongini, M., Langer, M., Miceli, R., & Mariani, L. (2011) · Liver Transplantation · doi:10.1002/lt.22365 · Cited by 593
Franchis, R. D. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80320-7 · Cited by 587
Leung, T. W. T., Tang, A. M. Y., Zee, B., Lau, W. Y., Lai, P. B. S., Leung, K. L., Lau, J. T. F., Yu, S. C. H., & Johnson, P. J. (2002) · Cancer · doi:10.1002/cncr.10384 · Cited by 583
Survival and prognostic indicators in compensated and decompensated cirrhosis
D'amico, G., Morabito, A., Pagliaro, L., Marubini, E., & The Liver Study Group of ?V. Cervello? Hospital (1986) · Digestive Diseases and Sciences · doi:10.1007/bf01320309 · Cited by 575
Risk Factors for Mortality After Surgery in Patients With Cirrhosis
Teh, S. H., Nagorney, D. M., Stevens, S. R., Offord, K. P., Therneau, T. M., Plevak, D. J., Talwalkar, J. A., Kim, W. R., & Kamath, P. S. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.01.040 · Cited by 570
Reactivation of hepatitis B # †
Hoofnagle, J. H. (2009) · Hepatology · doi:10.1002/hep.22945 · Cited by 570
Gastric cancer treatment guidelines in Japan
Nakajima, T. (2002) · Gastric Cancer · doi:10.1007/s101200200000 · Cited by 569
Clarification of Risk Factors for Abdominal Operations in Patients with Hepatic Cirrhosis
GARRISON, R. N., CRYER, H. M., POLK, H. C., & HOWARD, D. A. (1984) · Annals of Surgery · doi:10.1097/00000658-198406000-00003 · Cited by 547
Competing risks and prognostic stages of cirrhosis: a 25‐year inception cohort study of 494 patients
D'Amico, G., Pasta, L., Morabito, A., D'Amico, M., Caltagirone, M., Malizia, G., Tinè, F., Giannuoli, G., Traina, M., Vizzini, G., et al. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12721 · Cited by 547
Emerging trends in hepatocellular carcinoma incidence and mortality
Njei, B., Rotman, Y., Ditah, I., & Lim, J. K. (2015) · Hepatology · doi:10.1002/hep.27388 · Cited by 539
Garcia‐Tsao, G., Friedman, S., Iredale, J., & Pinzani, M. (2010) · Hepatology · doi:10.1002/hep.23478 · Cited by 538
Raoul, J.-L., Sangro, B., Forner, A., Mazzaferro, V., Piscaglia, F., Bolondi, L., & Lencioni, R. (2011) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2010.07.006 · Cited by 537
Epidemiology of Alcoholic Liver Disease
Grant, B., Dufour, M., & Harford, T. (1988) · Seminars in Liver Disease · doi:10.1055/s-2008-1040525 · Cited by 536
The hepatic venous pressure gradient: Anything worth doing should be done right
Groszmann, R. J., & Wongcharatrawee, S. (2004) · Hepatology · doi:10.1002/hep.20062 · Cited by 524
Palmer, W. C., & Patel, T. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.022 · Cited by 517
A new prognostic classification for predicting survival in patients with hepatocellular carcinoma
Chevret, S., Trinchet, J.-C., Mathieu, D., Rached, A. A., Beaugrand, M., & Chastang, C. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80173-1 · Cited by 512
Perrillo, R. P., Gish, R., & Falck-Ytter, Y. T. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.10.038 · Cited by 504
Complications of cirrhosis. I. Portal hypertension
Bosch, J., & García-Pagán, J. C. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80422-5 · Cited by 490
Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up
Glynne-Jones, R., Nilsson, P. J., Aschele, C., Goh, V., Peiffert, D., Cervantes, A., & Arnold, D. (2014) · European Journal of Surgical Oncology (EJSO) · doi:10.1016/j.ejso.2014.07.030 · Cited by 481
Cabibbo, G., Enea, M., Attanasio, M., Bruix, J., Craxì, A., & Cammà, C. (2010) · Hepatology · doi:10.1002/hep.23485 · Cited by 473
Esteve, M., Saro, C., González-Huix, F., Suarez, F., Forné, M., & Viver, J. M. (2004) · Gut · doi:10.1136/gut.2004.040675 · Cited by 467
Cho, Y. K., Kim, J. K., Kim, M. Y., Rhim, H., & Han, J. K. (2009) · Hepatology · doi:10.1002/hep.22648 · Cited by 466
Loomba, R., Rowley, A., Wesley, R., Liang, T. J., Hoofnagle, J. H., Pucino, F., & Csako, G. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-7-200804010-00008 · Cited by 459
Hepatotoxicity of Chemotherapy
King, P. D., & Perry, M. C. (2001) · The Oncologist · doi:10.1634/theoncologist.6-2-162 · Cited by 454
Nakano, H., Oussoultzoglou, E., Rosso, E., Casnedi, S., Chenard-Neu, M.-P., Dufour, P., Bachellier, P., & Jaeck, D. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e31815774de · Cited by 449
Sala, M., Llovet, J. M., Vilana, R., Bianchi, L., Solé, M., Ayuso, C., Brú, C., & Bruix, J. (2004) · Hepatology · doi:10.1002/hep.20465 · Cited by 447
Poschl, G. (2004) · Alcohol and Alcoholism · doi:10.1093/alcalc/agh057 · Cited by 442
Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma
Khan, S. A., Toledano, M. B., & Taylor-Robinson, S. D. (2008) · HPB · doi:10.1080/13651820801992641 · Cited by 431
Assessment of Prognosis of Cirrhosis
Durand, F., & Valla, D. (2008) · Seminars in Liver Disease · doi:10.1055/s-2008-1040325 · Cited by 410
Benjamin, R. S., Wiernik, P. H., & Bachur, N. R. (1974) · Cancer · doi:10.1002/1097-0142(197401)33:1<19::aid-cncr2820330107>3.0.co;2-m · Cited by 390
Berzigotti, A., Reig, M., Abraldes, J. G., Bosch, J., & Bruix, J. (2015) · Hepatology · doi:10.1002/hep.27431 · Cited by 385
Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968–1998
Taylor-Robinson, S. D., Toledano, M. B., Arora, S., Keegan, T. J., Hargreaves, S., Beck, A., Khan, S. A., Elliott, P., & Thomas, H. C. (2001) · Gut · doi:10.1136/gut.48.6.816 · Cited by 381
Kim, Y.-S., Lim, H. K., Rhim, H., Lee, M. W., Choi, D., Lee, W. J., Paik, S. W., Koh, K. C., Lee, J. H., Choi, M. S., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.09.020 · Cited by 372
Kadalayil, L., Benini, R., Pallan, L., O'Beirne, J., Marelli, L., Yu, D., Hackshaw, A., Fox, R., Johnson, P., Burroughs, A. K., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt247 · Cited by 370
Evens, A. M., Jovanovic, B. D., Su, Y., Raisch, D. W., Ganger, D. R., Belknap, S. M., Dai, M.-S., Chiu, B.-C. C., Fintel, B., Cheng, Y., et al. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq583 · Cited by 353
Iavarone, M., Cabibbo, G., Piscaglia, F., Zavaglia, C., Grieco, A., Villa, E., Cammà, C., & Colombo, M. (2010) · Hepatology · doi:10.1002/hep.24644 · Cited by 352
Sieghart, W., Hucke, F., Pinter, M., Graziadei, I., Vogel, W., Müller, C., Heinzl, H., Trauner, M., & Peck-Radosavljevic, M. (2013) · Hepatology · doi:10.1002/hep.26256 · Cited by 343
Self-citationNorthup, P. G., Wanamaker, R. C., Lee, V. D., Adams, R. B., & Berg, C. L. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000171327.29262.e0 · Cited by 337
Transarterial chemoembolization: Modalities, indication, and patient selection
Sieghart, W., Hucke, F., & Peck-Radosavljevic, M. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.010 · Cited by 336
Self-citationSørensen, H. T., Friis, S., Olsen, J. H., Thulstrup, A. M., Mellemkjær, L., Linet, M., Trichopoulos, D., Vilstrup, H., & Olsen, J. (1998) · Hepatology · doi:10.1002/hep.510280404 · Cited by 328
Bolondi, L., Burroughs, A. K., Dufour, J.-F., Galle, P. R., Mazzaferro, V., Piscaglia, F., Raoul, J., & Sangro, B. (2012) · BORIS (University Library Bern) · Cited by 320
The management of portal hypertension: Rational basis, available treatments and future options
Bosch, J., Berzigotti, A., Garcia-Pagan, J. C., & Abraldes, J. G. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.021 · Cited by 319
Trends in Organ Donation and Transplantation in the United States, 1999-2008
Wolfe, R. A., Roys, E. C., & Merion, R. M. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03021.x · Cited by 313
Lalazar, G., Rund, D., & Shouval, D. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06465.x · Cited by 311
Tao, R., Krishnan, S., Bhosale, P. R., Javle, M. M., Aloia, T. A., Shroff, R. T., Kaseb, A. O., Bishop, A. J., Swanick, C. W., Koay, E. J., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.3778 · Cited by 309
Lee, D. H., Lee, J. M., Lee, J. Y., Kim, S. H., Yoon, J. H., Kim, Y. J., Han, J. K., & Choi, B. I. (2014) · Radiology · doi:10.1148/radiol.13130940 · Cited by 308
Hsu, C., Hsiung, C. A., Su, I.-J., Hwang, W.-S., Wang, M.-C., Lin, S.-F., Lin, T.-H., Hsiao, H.-H., Young, J.-H., Chang, M.-C., et al. (2008) · Hepatology · doi:10.1002/hep.22106 · Cited by 305
Spanish Experience in Liver Transplantation for Hilar and Peripheral Cholangiocarcinoma
Robles, R., Figueras, J., Turrión, V. S., Margarit, C., Moya, A., Varo, E., Calleja, J., Valdivieso, A., Valdecasas, J. C. G., López, P., et al. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000108702.45715.81 · Cited by 304
Germani, G., Pleguezuelo, M., Gurusamy, K., Meyer, T., Isgrò, G., & Burroughs, A. K. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.12.004 · Cited by 304
Gastric cancer: ESMO–ESSO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Waddell, T., Verheij, M., Allum, W., Cunningham, D., Cervantes, A., & Arnold, D. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt344 · Cited by 303
Mejias, M., Garcia-Pras, E., Tiani, C., Miquel, R., Bosch, J., & Fernandez, M. (2009) · Hepatology · doi:10.1002/hep.22758 · Cited by 293
Hepatotoxicity of Chemotherapy
Floyd, J., Mirza, I., Sachs, B., & Perry, M. C. (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2005.11.002 · Cited by 279
Valle, J. W., Wasan, H., Johnson, P., Jones, E., Dixon, L., Swindell, R., Baka, S., Maraveyas, A., Corrie, P., Falk, S., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605211 · Cited by 270
Orlando, A., Leandro, G., Olivo, M., Andriulli, A., & Cottone, M. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.80 · Cited by 257
Luca, A., Angermayr, B., Bertolini, G., Koenig, F., Vizzini, G., Ploner, M., Peck-Radosavljevic, M., Gridelli, B., & Bosch, J. (2007) · Liver Transplantation · doi:10.1002/lt.21197 · Cited by 249
Self-citationHepatocellular carcinoma in Central Europe: prognostic features and survival
Schöniger-Hekele, M., Müller, C., Kutilek, M., Oesterreicher, C., Ferenci, P., & Gangl, A. (2001) · Gut · doi:10.1136/gut.48.1.103 · Cited by 228
Aapro, M. S., Martin, C., & Hatty, S. (1998) · Anti-Cancer Drugs · doi:10.1097/00001813-199803000-00001 · Cited by 228
Shimoda, M., Farmer, D. G., Colquhoun, S. D., Rosove, M., Ghobrial, M. R., Yersiz, H., Chen, P., & Busuttil, R. W. (2001) · Liver Transplantation · doi:10.1053/jlts.2001.29419 · Cited by 220
Longitudinal assessment of mortality risk among candidates for liver transplantation
Merion, R. M., Wolfe, R. A., Dykstra, D. M., Leichtman, A. B., Gillespie, B., & Held, P. J. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50009 · Cited by 216
Prophylaxis and treatment of hepatitis B in immunocompromised patients
Marzano, A., Angelucci, E., Andreone, P., Brunetto, M., Bruno, R., Burra, P., Caraceni, P., Daniele, B., Di Marco, V., Fabrizi, F., et al. (2007) · Digestive and Liver Disease · doi:10.1016/j.dld.2006.12.017 · Cited by 211
Measurement of Portal Pressure and Its Role in the Management of Chronic Liver Disease
Bosch, J., Garcia-Pagán, J. C., Berzigotti, A., & Abraldes, J. (2006) · Seminars in Liver Disease · doi:10.1055/s-2006-951603 · Cited by 206
Jiao, J., Friedman, S. L., & Aloman, C. (2009) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3283279668 · Cited by 203
Sapisochin, G., Rodríguez de Lope, C., Gastaca, M., Ortiz de Urbina, J., Suarez, M. A., Santoyo, J., Castroagudín, J. F., Varo, E., López-Andujar, R., Palacios, F., et al. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12591 · Cited by 197
Hong, J. C. (2011) · Archives of Surgery · doi:10.1001/archsurg.2011.116 · Cited by 196
Venook, A. P., Egorin, M. J., Rosner, G. L., Hollis, D., Mani, S., Hawkins, M., Byrd, J., Hohl, R., Budman, D., Meropol, N. J., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.14.2780 · Cited by 194
Cornberg, M., Protzer, U., Petersen, J., Wedemeyer, H., Berg, T., Jilg, W., Erhardt, A., Wirth, S., Sarrazin, C., Dollinger, M., et al. (2011) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0031-1273462 · Cited by 193
Surgery in the patient with liver disease.
Friedman, L. S. (2010) · PubMed · Cited by 189
Al-Adra, D. P., Gill, R. S., Axford, S. J., Shi, X., Kneteman, N., & Liau, S.-S. (2015) · European Journal of Surgical Oncology (EJSO) · doi:10.1016/j.ejso.2014.09.007 · Cited by 187
Liver Cirrhosis Mortality in Europe, with Special Attention to Central and Eastern Europe
Zatoński, W. A., Sulkowska, U., Mańczuk, M., Rehm, J., Boffetta, P., Lowenfels, A. B., & La Vecchia, C. (2010) · European Addiction Research · doi:10.1159/000317248 · Cited by 181 · cited 1×
“people die from complications of cirrhosis per year.(3) Second, liver cirrhosis is a wellknown risk factor for primary liver cancer(4) 5 but also increases the risk of developing extrahepatic malignancies.”
BackgroundExtended Hepatic Resection for Hepatocellular Carcinoma in Patients with Cirrhosis: Is It Justified?
Poon, R. T. P., Fan, S. T., Lo, C. M., Liu, C. L., Lam, C. M., Yuen, W. K., Yeung, C., & Wong, J. (2002) · Annals of Surgery · doi:10.1097/00000658-200211000-00010 · Cited by 179
Sorafenib in Unresectable Hepatocellular Carcinoma from Mild to Advanced Stage Liver Cirrhosis
Pinter, M., Sieghart, W., Graziadei, I., Vogel, W., Maieron, A., Königsberg, R., Weissmann, A., Kornek, G., Plank, C., & Peck-Radosavljevic, M. (2009) · The Oncologist · doi:10.1634/theoncologist.2008-0191 · Cited by 178
Self-citationPaul, S., Saxena, A., Terrin, N., Viveiros, K., Balk, E. M., & Wong, J. B. (2016) · Annals of Internal Medicine · doi:10.7326/m15-1121 · Cited by 177
Management of colorectal cancer presenting with synchronous liver metastases
Siriwardena, A. K., Mason, J. M., Mullamitha, S., Hancock, H. C., & Jegatheeswaran, S. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.90 · Cited by 176
Management of chemotherapy-associated hepatotoxicity in colorectal liver metastases
Chun, Y. S., Laurent, A., Maru, D., & Vauthey, J.-N. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70064-6 · Cited by 173
Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer
Torres, H. A., & Davila, M. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.1 · Cited by 169
Sakamoto, Y., Kokudo, N., Matsuyama, Y., Sakamoto, M., Izumi, N., Kadoya, M., Kaneko, S., Ku, Y., Kudo, M., Takayama, T., et al. (2016) · Cancer · doi:10.1002/cncr.29686 · Cited by 168
The surgical approach to HCC: Our progress and results in Japan
Makuuchi, M., & Sano, K. (2004) · Liver Transplantation · doi:10.1002/lt.20044 · Cited by 166
Kiefer, M. V., Albert, M., McNally, M., Robertson, M., Sun, W., Fraker, D., Olthoff, K., Christians, K., Pappas, S., Rilling, W., et al. (2011) · Cancer · doi:10.1002/cncr.25625 · Cited by 160
Hucke, F., Pinter, M., Graziadei, I., Bota, S., Vogel, W., Müller, C., Heinzl, H., Waneck, F., Trauner, M., Peck-Radosavljevic, M., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.07.002 · Cited by 159
Self-citationBouza, C., López‐Cuadrado, T., Alcázar, R. A., Saz‐Parkinson, Z., & Amate, J. M. (2009) · BMC Gastroenterology · doi:10.1186/1471-230x-9-31 · Cited by 159
Pressiani, T., Boni, C., Rimassa, L., Labianca, R., FAGIUOLI, S., Salvagni, S., Ferrari, D., Cortesi, E., Porta, C., Mucciarini, C., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds343 · Cited by 154
Park, S.-Y., Kim, J. H., Yoon, H.-J., Lee, I., Yoon, H., & Kim, K.-P. (2011) · Clinical Radiology · doi:10.1016/j.crad.2010.11.002 · Cited by 152
Wörns, M., Weinmann, A., Pfingst, K., Schulte-Sasse, C., Messow, C., Schulze‐Bergkamen, H., Teufel, A., Schuchmann, M., Kanzler, S., Düber, C., et al. (2009) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31818ddfc6 · Cited by 149
Portal hypertension: from pathophysiology to clinical practice
Laleman, W., Landeghem, L. V., Wilmer, A. P., Fevery, J., & Nevens, F. (2005) · Liver International · doi:10.1111/j.1478-3231.2005.01163.x · Cited by 149
Alcohol and cancer: genetic and nutritional aspects
Pöschl, G., Stickel, F., Wang, X. D., & Seitz, H. K. (2004) · Proceedings of The Nutrition Society · doi:10.1079/pns2003323 · Cited by 146
Gibbons, J., Egorin, M. J., Ramanathan, R. K., Fu, P., Mulkerin, D. L., Shibata, S., Takimoto, C. H. M., Mani, S., LoRusso, P. M., Grem, J. L., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.3819 · Cited by 146
Liver transplantation for incidental cholangiocarcinoma: Analysis of the Canadian experience
Ghali, P., Marotta, P. J., Yoshida, E. M., Bain, V. G., Marleau, D., Peltekian, K. M., Metrakos, P. P., & Deschênes, M. (2005) · Liver Transplantation · doi:10.1002/lt.20512 · Cited by 145
Part I: Liver function in oncology: biochemistry and beyond
Field, K. M., Dow, C., & Michael, M. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70279-1 · Cited by 145
Hepatitis B Virus Reactivation After Cytotoxic Chemotherapy: The Disease and Its Prevention
Mindikoglu, A. L., Regev, A., & Schiff, E. R. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.05.027 · Cited by 136
Kim, B. K., Park, J. Y., Kim, D. Y., Kim, J. K., Kim, K. S., Choi, J. S., Moon, B. S., Han, K., Chon, C. Y., Moon, Y. M., et al. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01625.x · Cited by 131
Surgery in the Patient with Liver Disease
O’Leary, J. G., Yachimski, P., & Friedman, L. S. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2009.02.002 · Cited by 130
Hucke, F., Sieghart, W., Pinter, M., Graziadei, I. W., Vogel, W., Müller, C., Heinzl, H., Waneck, F., Trauner, M., & Peck‐Radosavljevic, M. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.08.022 · Cited by 126
Self-citationAssessment of risk for non-hepatic surgery in cirrhotic patients
Bhangui, P., Laurent, A., Amathieu, R., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.03.037 · Cited by 126
Vento, S., Cainelli, F., & Longhi, M. S. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00773-8 · Cited by 125
Carbone, D. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90621-h · Cited by 123
Singal, A. K., Freeman, D. H., Jr., & Anand, B. S. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04414.x · Cited by 122
Treatment of unresectable cholangiocarcinoma
Kuhlmann, J. B., Euringer, W., Spangenberg, H. C., Breidert, M., Blum, H. E., Harder, J., & Fischer, R. (2012) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3283502241 · Cited by 122
Hepatitis B reactivation after chemotherapy: two decades of clinical research
Lau, G. K. K. (2008) · Hepatology International · doi:10.1007/s12072-008-9056-3 · Cited by 121
Increased Risk for Malignant Neoplasms Among Patients With Cirrhosis
Kalaitzakis, E., Gunnarsdóttir, S. A., Josefsson, A., & Bjornsson, E. S. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.10.014 · Cited by 121
Safety and efficacy of sorafenib in hepatocellular carcinoma: the impact of the Child-Pugh score
Hollebecque, A., Cattan, S., Romano, O., Sergent, G., Mourad, A., Louvet, A., Dharancy, S., Boleslawski, E., Truant, S., Pruvot, F., et al. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04860.x · Cited by 119
Raymond, É., Boige, V., Faivre, S. J., Sanderink, G., Rixe, O., Vernillet, L., Jacques, C. J., Gatineau, M., Ducreux, M. P., & Armand, J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.03.123 · Cited by 119
Zuckerman, E., Zuckerman, T., Douer, D., Qian, D., & Levine, A. M. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980915)83:6<1224::aid-cncr23>3.0.co;2-6 · Cited by 115
Abou‐Alfa, G. K., Amadori, D., Santoro, A., Figer, A., Grève, J. D., Lathia, C. D., Voliotis, D., Anderson, S. E., Moscovici, M., & Ricci, S. (2011) · Europe PMC (PubMed Central) · Cited by 109
Predicting etoposide toxicity: relationship to organ function and protein binding.
Joel, S. P., Shah, R., CLARK, P. I., & Slevin, M. L. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.1.257 · Cited by 107
Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats
Reiberger, T., Angermayr, B., Schwabl, P., Rohr‐Udilova, N., Mitterhauser, M., Gangl, A., & Peck‐Radosavljevic, M. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.06.024 · Cited by 107
Self-citationLi, N., Lai, E. C. H., Shi, J., Guo, W., Xue, J., Huang, B. S., Lau, W. Y., Wu, M., & Cheng, S. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0694-z · Cited by 106
Risk of hepatitis B surface antigen seroreversion after allogeneic hematopoietic SCT
Viganò, M., Vener, C., Lampertico, P., Annaloro, C., Pichoud, C., Zoulim, F., Facchetti, F., Poli, F., Scalamogna, M., Deliliers, G. L., et al. (2010) · Bone Marrow Transplantation · doi:10.1038/bmt.2010.70 · Cited by 102
Smoking and risk of liver cirrhosis: a population-based cohort study
Dam, M. K., Flensborg‐Madsen, T., Eliasen, M., Becker, U., & Tolstrup, J. S. (2013) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2013.777469 · Cited by 101
Pinter, M., Sieghart, W., Reiberger, T., Rohr‐Udilova, N., Ferlitsch, A., & Peck‐Radosavljevic, M. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04896.x · Cited by 99
Self-citationImproving the Diagnosis of Acute Hepatitis C Virus Infection with Expanded Viral Load Criteria
McGovern, B., Birch, C. E., Bowen, M. J., Reyor, L. L., Nagami, E. H., Chung, R. T., & Kim, A. Y. (2009) · Clinical Infectious Diseases · doi:10.1086/605561 · Cited by 99
Vos, J. J., Wietasch, G. J. K. G., Absalom, A. R., Hendriks, H. G. D., & Scheeren, T. (2014) · Anaesthesia · doi:10.1111/anae.12755 · Cited by 95
Commentary: Oncologic Drugs in Patients with Organ Dysfunction: A Summary
Superfin, D., Iannucci, A. A., & Davies, A. M. (2007) · The Oncologist · doi:10.1634/theoncologist.12-9-1070 · Cited by 93
Ramanathan, R. K., Egorin, M. J., Takimoto, C. H. M., Remick, S. C., Doroshow, J. H., LoRusso, P. M., Mulkerin, D. L., Grem, J. L., Hamilton, A. L., Murgo, A. J., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.0304 · Cited by 93
Antecedent liver disease and drug toxicity
Schenker, S., Martin, R. R., & Hoyumpa, A. M. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80325-0 · Cited by 90
Ratib, S., Fleming, K. M., Crooks, C. J., Walker, A. J., & West, J. (2015) · The American Journal of Gastroenterology · doi:10.1038/ajg.2015.191 · Cited by 89
Part II: Liver function in oncology: towards safer chemotherapy use
Field, K. M., & Michael, M. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70307-3 · Cited by 89
Sorafenib for hepatocellular carcinoma according to Child-Pugh class of liver function
Kim, J. E., Ryoo, B., Ryu, M., Chang, H.-M., Suh, D. J., Lee, H. C., Lim, Y., Kim, K. M., & Kang, Y. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1616-x · Cited by 85
The option of HBIG-free prophylaxis against recurrent HBV
Fox, A. N., & Terrault, N. A. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.08.026 · Cited by 82
Kitai, S., Kudo, M., Minami, Y., Haji, S., Osaki, Y., Oka, H., Seki, T., Kasugai, H., Sasaki, Y., & Matsunaga, T. (2008) · Oncology · doi:10.1159/000173428 · Cited by 81
Venook, A. P., Klein, C. E., Fleming, G. F., Hollis, D. R., Leichman, C. G., Hohl, R. J., Byrd, J. C., Budman, D. R., Villalona, M. A., Marshall, J. L., et al. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg493 · Cited by 81
Review article: steatosis, the metabolic syndrome and cancer
Bugianesi, E. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02594.x · Cited by 80
Locasciulli, A., Bruno, B., Alessandrino, E. P., Meloni, G., Arcese, W., Bandini, G., Cassibba, V., Rotoli, B., Morra, E., Majolino, I., et al. (2003) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1703826 · Cited by 78
Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib
Pinter, M., Sieghart, W., Hucke, F., Graziadei, I., Vogel, W., Maieron, A., Königsberg, R., Weißmann, A.-C., Kornek, G. V., Matejka, J., et al. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04823.x · Cited by 77
Self-citationPerioperative chemotherapy for resectable hepatic metastases
Kopetz, S., & Vauthey, J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60429-8 · Cited by 76
Pinter, M., Ulbrich, G., Sieghart, W., Kölblinger, C., Reiberger, T., Li, S., Ferlitsch, A., Müller, C., Lämmer, J., & Peck‐Radosavljevic, M. (2015) · Radiology · doi:10.1148/radiol.2015142140 · Cited by 76
Self-citationHennenberg, M., Trebicka, J., Stark, C., Kohistani, A. Z., Heller, J., & Sauerbruch, T. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00158.x · Cited by 75
Colorectal Adenocarcinoma in Cirrhotic Patients
Gervaz, P., Pak‐art, R., Nivatvongs, S., Wolff, B. G., Larson, D., & Ringel, S. (2003) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(03)00117-0 · Cited by 73
Shibata, S., Chung, V. M., Synold, T. W., Longmate, J., Suttle, A. B., Ottesen, L. H., Lenz, H., Kummar, S., Harvey, R. D., Hamilton, A. L., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3214 · Cited by 73
Tolerance and outcome of patients with unresectable hepatocellular carcinoma treated with sorafenib
Ozenne, V., Paradis, V., Pernot, S., Castelnau, C., Vullierme, M., Bouattour, M., Valla, D. C., Farges, O., & Degos, F. (2010) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3283386053 · Cited by 72
Miller, A. A., Murry, D. J., Owzar, K., Hollis, D. R., Lewis, L. D., Kindler, H. L., Marshall, J. L., Villalona-Calero, M. A., Edelman, M. J., Hohl, R. J., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.6210 · Cited by 71
Chiu, J. W. Y., Tang, Y. F., Yao, T., Wong, A., Wong, H., Leung, R. C.-Y., Chan, P., Cheung, T. T., Chan, A. C. Y., Pang, R. W. C., et al. (2012) · Cancer · doi:10.1002/cncr.27543 · Cited by 69
Influences of tobacco and alcohol use on hepatocellular carcinoma survival
Shih, W., Chang, H., Liaw, Y., Lin, S., Lee, S., Chen, P., Liu, C., Lin, C., & Yu, M. (2012) · International Journal of Cancer · doi:10.1002/ijc.27508 · Cited by 68
Cho, Y., Yu, S. J., Cho, E. J., Lee, J., Kim, T. M., Heo, D. S., Kim, Y. J., & Yoon, J. (2015) · Journal of Medical Virology · doi:10.1002/jmv.24423 · Cited by 68
Reversible Decrease of Portal Venous Flow in Cirrhotic Patients: A Positive Side Effect of Sorafenib
Coriat, R., Gouya, H., Mir, O., Ropert, S., Vignaux, O., Chaussade, S., Sogni, P., Pol, S., Blanchet, B., Legmann, P., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016978 · Cited by 67
Prognostic Value of Cirrhosis for Intrahepatic Cholangiocarcinoma After Surgical Treatment
Li, Y., Li, H., Lv, P., Liu, G., Li, X., Tian, B., & Chen, D. (2011) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-011-1419-8 · Cited by 66
Bernhard, M. W. S., Junker, E., Hettinger, A., & Lauterburg, B. H. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80223-7 · Cited by 64
Tolerance after liver transplantation: does it exist and can immunosuppression be withdrawn?
Riordan, S. M., & Williams, R. L. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80326-2 · Cited by 63
Hucke, F., Sieghart, W., Schöniger–Hekele, M., Peck‐Radosavljevic, M., & Müller, C. (2011) · Wiener klinische Wochenschrift · doi:10.1007/s00508-011-0033-9 · Cited by 62
Self-citationComplications Following Hepatectomy
Russell, M. C. (2014) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2014.09.008 · Cited by 62
Cancer, Coagulation, and Anticoagulation
Letai, A., & Kuter, D. J. (1999) · The Oncologist · doi:10.1634/theoncologist.4-6-443 · Cited by 62
Cited by
Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy
Pinter, M., & Jain, R. K. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aan5616 · Cited by 332
Self-citationScheiner, B., Pomej, K., Kirstein, M. M., Hucke, F., Finkelmeier, F., Waidmann, O., Himmelsbach, V., Schulze, K., von Felden, J., Fründt, T. W., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2021.09.035 · Cited by 303
Self-citationMa, X., Yu, C., Wang, P., Xu, W., Wan, X., Lai, C. S. E., Liu, J., Koroleva-Maharajh, A., & Chen, S. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.09.026 · Cited by 281
Álvarez-Mercado, A. I., Caballeria-Casals, A., Rojano-Alfonso, C., Chávez-Reyes, J., Micó-Carnero, M., Sanchez-Gonzalez, A., Casillas-Ramírez, A., Gracia-Sancho, J., & Peralta, C. (2021) · Biomedicines · doi:10.3390/biomedicines9091158 · Cited by 12
Ullah, I., Seo, K., Wi, H., Kim, Y., Lee, S., & Ock, S. A. (2020) · Animal Cells and Systems · doi:10.1080/19768354.2020.1823473 · Cited by 4
“However, this strategy is not viable for many patients with liver disorders owing the limited supply of organs (Pinter et al. 2016; Artur et al. 2017).”
Background
Metadata
- Authors
- Pinter, M., Trauner, M., Peck-Radosavljevic, M., & Sieghart, W.
- Venue
- ESMO Open
- Publisher
- Elsevier BV
- Published
- 2016
- Volume
- 1
- Issue
- 2
- Pages
- e000042
- ISSN
- 2059-7029 (ISSN-L)
- OpenAlex
- W2318933482
- Cited by
- 295
- References
- 223
- FWCI
- 15.79
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.